Event Details

This course is predominantly aimed at non-scientists working within the Life Sciences industry in non-research roles and is especially relevant for employees who are new to the industry or who have more established professional dealings with it.


It covers the structure and commercial environment of the biopharmaceutical industry and highlights the processes required to move a drug candidate from the discovery laboratory through to the marketplace.


If you are however a research scientist, keen to become more attuned to the commercial environment of the Life Sciences industry and the formal drug development process, some benefit will still be gained from attending this course, but please be aware that there will an element of crossover with your existing knowledge.'


The Commercial Landscape

Global pharmaceutical sales

Market breakdown

Pharma companies

Products


Drug Discovery & Development

Therapeutic areas

The expanding drug landscape

The drug discovery pipeline

Regulatory agencies

Preclinical development

Clinical and regulatory phases


Industry challenges

Market pressures

Intellectual property

Improving R&D success rate:

Target discovery

Small molecule development

Biologicals incl. cell and gene therapy

Impact of machine learning/AI

Learning from COVID-19 era



This course will be delivered on Thursday 17th March 2022 between 12:00-17:00 LIVE in person. All catering and course materials are included in the course costs.



Event Terms & Conditions

Venue

The Oxford Science Park
England, United Kingdom

If you have any questions please contact Isabel Coleman

Contact Organizer

Show on map

Speakers

Tickets

OBN Member
Member Price £200
Non-Member
Standard Price £350